An exploration of individual- and population-level impact of the 2-dose HPV vaccination schedule in pre-adolescent girls

Item

http://www.wikidata.org/entity/Q37135276

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

An exploration of individual- ...... hedule in pre-adolescent girls

@en

An exploration of individual- ...... edule in pre-adolescent girls.

@nl

type

Item

label

An exploration of individual- ...... hedule in pre-adolescent girls

@en

An exploration of individual- ...... edule in pre-adolescent girls.

@nl

prefLabel

An exploration of individual- ...... hedule in pre-adolescent girls

@en

An exploration of individual- ...... edule in pre-adolescent girls.

@nl

P1476

An exploration of individual- ...... hedule in pre-adolescent girls

@en

P2093

Chris J L M Meijer

http://www.w3.org/2001/XMLSchema#string

Fiona R M van der Klis

http://www.w3.org/2001/XMLSchema#string

Hester E de Melker

http://www.w3.org/2001/XMLSchema#string

Johannes A Bogaards

http://www.w3.org/2001/XMLSchema#string

Robine Donken

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)

FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.

Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data.

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study.

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types

Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.

P304

1381-1393

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/21645515.2016.1160978

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2016-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27171128

http://www.w3.org/2001/XMLSchema#string

P921

teenager

biomedical investigative technique

tumor virus infections

P932

4964747

http://www.w3.org/2001/XMLSchema#string